Large non-polypoid colorectal adenomas that spread over the mucosa and morphologically flat lesions are included in a group called granule-aggregating tumours. These are uncommon in the West. We aimed to clarify the biological differences between granule-aggregating tumours and colorectal polypoid adenomas. We evaluated the extent of apoptotic cell loss and expression of bcl-2 and p53 oncoproteins in 26 granule-aggregating tumours and 19 polypoid adenomas. The mean apoptosis index value of granuleaggregating tumours was significantly higher than that of polypoid adenomas. Only two (7.7%) granule-aggregating tumours and 13 (68.4%) polypoid colorectal adenomas expressed bcl-2, while 12 (46.2%) granule-aggregating tumours and six (31.6%) polypoid colorectal adenomas were p53-positive. Our results show that the higher apoptosis index and frequent expression of bcl-2 oncoprotein differentiates granule-aggregating tumours from polypoid colorectal adenomas. We propose that large non-polypoid granuleaggregating tumours of the colorectum are a biologically distinct entity.
Introduction
Screening for colon polyps has been shown to reduce the risk of colorectal cancer. 1 On the basis of the adenoma-carcinoma sequence theory, 2 colorectal adenomas exceeding 20 mm in diameter frequently develop malignant components that invade the submucosal layer. 3, 4 Morphologically, most of these tumours are sessile, pedunculated or polyps. In contrast, many large lesions with non-polypoid appearance characteristically spread laterally rather than vertically. 5 -7 These unique colorectal lesions have been given various names in Japan, such as laterally spreading tumours, 5 nodule-aggregating tumours 6 or granuleaggregating tumours (GATs). 8 In a previous study to determine whether large nonpolypoid colorectal neoplasms are a distinct entity, we reported that the group with a granule-aggregating appearance (called GATs in this study) showed a distinct clinical course. 8 Interestingly, in contrast to large polypoid adenomas (PAs), GATs rarely display a carcinomatous component with submucosal invasion, even when they are larger than 20 mm in diameter. 5 The concept of large non-polypoid colonic lesions is gradually being accepted worldwide, 9 but their precise biological characteristics remain unknown.
We aimed to clarify the distinguishing biological characteristics of two types of colorectal adenomas, GATs and PAs, measuring 10 mm or more and showing different growth patterns.
Patients and methods

PATIENTS
Patients who had had GAT or PA colorectal tumours endoscopically or surgically removed at the Yamanashi Medical University Hospital between 1995 and 2000 were included in the study. These patients have been reported previously. 8, 10 Granule-aggregating tumours were defined as colorectal laterally spreading tumours with granule-aggregating appearance and being composed of granules or elevations (macroscopically measuring less than 3 mm) of small flat lesions projecting above the surrounding mucosa (Figs 1 and 2). All GATs we studied measured more than 10 mm. No apparent ulcer formation was seen on the tumour surface, and they were histologically classified as tubular adenomas and tubulovillous adenomas with the villous component accounting for 0 -24% and 25 -74% of the tumour, respectively.
Polypoid adenomas were defined as protruding colorectal adenomas, including sessile and pedunculated forms, measuring 10 mm or more.
Patients with familial adenomatous polyposis or hereditary non-polypoid colorectal cancer were excluded from the study.
The study was done in accordance with the principles of the Declaration of Helsinki and all patients gave informed consent. According to the nosographic research guidelines of the Japanese Ministry of Education, Culture, Sport, Science and Technology (July 2002), the study did not need ethical approval.
TISSUE PREPARATION
Biopsies were taken endoscopically or surgically. 8, 10 All tissue specimens were fixed with 10% buffered formalin, routinely processed and embedded in paraffin for histological examination. Haematoxylin and eosin-stained slides of selected cases were reviewed by one pathologist (H Hasegawa). This person had no knowledge of the clinicopathological data and carried out all histological assessments. Samples were selected based on the findings of endoscopic examination; the histological diagnosis was based on the World Health Organization classification. 11 
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IMMUNOHISTOCHEMICAL STAINING
Sections for the examination of apoptosis were digested with proteinase K (20 µg/ml in phosphate buffered saline (PBS; Wako Chemicals, Osaka, Japan) at room temperature (RT) for 6 min. Sections for bcl-2 and p53 oncoprotein expressions were autoclaved in 0.01 M sodium citrate buffer (pH 6.0) at 121 ºC for 15 min. To block nonspecific reactions, deparaffinized tissue sections were routinely treated with a 3% H 2 O 2 solution at RT for 10 min, and 10% normal bovine serum for 5 min at RT.
Anti-single-stranded DNA (ssDNA) rabbit polyclonal antibody (A4506; DAKO, Glostrup, Denmark) at a 1:100 dilution, antihuman bcl-2 mouse monoclonal antibody (clone 124; DAKO, Glostrup, Denmark) at a 1:100 dilution and anti-human p53 mouse monoclonal antibody (clone Do-7; DAKO, Glostrup, Denmark) at a 1:50 dilution were used. All sections were incubated with the antibody overnight at 4 ºC. Histofine Simple Stain MAX PO (MULTI; Nichirei Co, Tokyo, Japan) was used as the secondary antibody and incubation was for 30 min at RT. After visualization with 3-3'-diaminobenzidine tetrahydrochloride, the sections were counterstained with haematoxylin. A negative control slide without primary antibody was included in each staining.
EVALUATION OF STAINING
Positively staining tumour cells with the morphological characteristics of apoptosis were identified using standard criteria, including chromatin condensation, nuclear disintegration and formation of crescent-shaped caps of condensed chromatin at the nuclear periphery. 12 Positively staining cells without signs of apoptosis or with cell bodies located in the stroma and lumens were excluded. Each lesion was divided into two parts, upper and lower half of the tumour, in which apoptotic cells were counted in each 1000 cell portion. At least five representative areas without necrosis in each portion were selected by light microscopy (magnification × 200).
Nuclear staining was considered positive for p53 protein. Cytoplasmic staining was the criterion for a positive bcl-2 reaction compared with the reactivity of infiltrating lymphocytes as controls. Both bcl-2 and p53 proteins were evaluated as positive if there was ≥ 10% immunostaining of tumour cells and as negative if < 10%.
STATISTICAL ANALYSIS
Fisher's exact test, Mann-Whitney U-test and Wilcoxon's signed-rank test were used for statistical analysis with a StatView J 5.0 ® (SAS Institute Inc., Cary, NC, USA). P-values < 0.05 were considered statistically significant.
Results
We examined 26 GATs from patients with a mean age of 64 years (range, 38 -83) and a male:female ratio of 16:10. The 19 PAs came from patients aged 47 -78 years (mean, 64) and 15 were male and four female. All PAs and 7 GATs were removed endoscopically, while 19 GATs were surgically excised.
The mean size of the GATs was 28 mm (range, 2 -62 mm) and for the PAs was 13 mm (range, 10 -19) . Histologically, 15 (58%) GATs and 13 (68%) PAs were classified as tubular adenomas, and 11 (42%) GATs and six (32%) PAs were tubulovillous adenomas. Nine (35%) GATs and 11 (58%) PAs showed mild/moderate dysplasia, and 17 (65%) GATs and eight (42%) PAs showed severe dysplasia. No GATs had carcinomatous components with submucosal invasion.
Positive nuclear or dot-like reactions to anti-ssDNA were mainly scattered throughout the lower part of the GATs (Fig. 3A) but the upper part of the PAs (Fig. 3B ). Tumour cells with cytoplasmic positive staining for bcl-2 (Fig. 4B ). Immunoreactivity to anti-p53 oncoprotein varied from case to case. In some cases both GATs and PAs showed sporadically or focally positive reactions (Fig. 5 ). The apoptosis index (AI) values and significant differences are shown in Table 1 .
The frequency of bcl-2 and p53 oncoprotein expression is shown in Table 2 . The expression of bcl-2 oncoprotein was significantly higher in PAs compared with GATs while p53 expression was not significantly different between the two groups.
Discussion
We believe that this is the first report documenting the biological basis of the growth patterns of large non-polypoid colorectal neoplasms by evaluating apoptosis and apoptosis-related proteins.
Large colorectal adenomas, greater than 10 mm in size, are divided into two types: polypoid and non-polypoid. Many protrusive polypoid lesions can be easily detected by endoscopy. In Japan, the frequency of detecting large non-polypoid colorectal lesions that characteristically appear as spreading laterally is increasing; 8 it is not known why this type of neoplasm shows such a unique pattern of growth and spread. In a preliminary investigation, we studied the extent of apoptotic cell loss in large non-polypoid colorectal adenomas and hypothesized that vertical growth seems to be inhibited by apoptosis. This phenomenon might allow horizontal growth and result in the characteristic laterally spreading pattern. 12 In the present study, to confirm our hypothesis, we compared the apoptotic patterns of GATs and PAs. Our data show that there is a predilection for apoptotic cell distribution, predominantly in the lower portions of GATs but the upper portions of PAs. These data support our hypothesis that development of both GATs and PAs is controlled by apoptosis. Investigation of the up-and down-regulators of apoptosis may clarify the biological nature of laterally spreading tumours.
The bcl-2 proto-oncogene is known to be an inhibitor of apoptosis and may allow accumulation of genetic mutations that propagate by cell division and potentially contribute to neoplastic development. 13 Generally, colorectal adenomas show high bcl-2 immunoreactivity 14, 15 and our data -68.4% positive in PAs -confirm this. Conversely, 92.3% of GATs were negative for the bcl-2 oncoprotein and were those accompanied by significantly higher AI values than those of the PAs. These data are consistent with the role of bcl-2 in apoptosis and the low bcl-2 oncoprotein expression in GATs is thought to be an important factor in the frequency of apoptosis expressed in these tumours. Furthermore, we propose that the low frequency of bcl-2 oncoprotein expression is 16 Mutant p53 has been reported to attenuate apoptosis, 17 and the expression of nuclear p53 in the tumour almost tallies with that of mutant p53. 18 The results of the present study are conflicting, since the mean AI value of p53-positive cases is significantly higher than that of p53-negative cases in both GATs and PAs. Various oncogenes and suppressor genes, including p53, the bcl-2 family, c-myc, ras and c-fos, regulate apoptosis. 19 A recent study using the antibody clone DO-7 demonstrated the presence of p53 in normal paraffin-embedded tissue. 20 To clarify the mechanism of over-expression of p53 with frequent apoptosis in large nonpolypoid and polypoid adenomas, we must investigate the expression of other oncogenes and suppressor genes or related proteins.
Early detection of flat and depressed colorectal neoplasms has been recommended since these rapidly invade the submucosal layers and form small tumours. 9, 21 Practically, these lesions are too small to detect. In contrast, we found that GATs were often over 20 mm in diameter (mean 28 mm) and that 65% had severe dysplastic features, generally considered a predictive marker of malignant potential. No case in the present study, however, showed a carcinomatous component with submucosal invasion, which seems to indicate slow growth based on the adenoma-carcinoma hypothesis; 8 apoptosis frequently occurs in slow-growing tumours. 22, 23 The high AI values and low bcl-2 oncoprotein expression in GATs may be the biological mechanisms responsible for their clinical behaviour, i.e., slow growth and infrequent development into invasive carcinomas.
In our previous study, one of the clinical characteristics of GATs was asymptomatic presentation, but cancers arising in other sites accompanied roughly one-third of GATs. 8 On the basis of these and current results, we believe that GATs are a distinct entity, characterized by endoscopic, clinical and biological features of large nonpolypoid colorectal neoplasms.
We re-emphasize that careful endoscopic screening of the digestive tract should be done for asymptomatic individuals, and that patients with GATs should undergo a fullbody examination because of the possibility of cancers in other organs. Despite their large size, however, GATs are infrequently discovered because the aggregating granules, measuring 1 -2 mm in size, spread laterally without protrusion. 8 Contrast chromoscopy with dye spraying and magnifying endoscopy 5, 21 should be used to increase the detection frequency of GATs and flat, depressed lesions. GATs and the flat, depressed colorectal tumours are both classified as superficial type tumours, 24 but have opposing characteristics in terms of development and progression.
We conclude that GATs are an important entity, not only for molecular biologists and epidemiologists investigating the aetiology of colorectal tumour, but also for clinical gastroenterologists. Practitioners should be aware of the existence and biological nature of GATs.
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